在系统性硬化症模型中,IL-21驱动皮肤和肺炎和纤维化

In Gyu Um1, Jin Seok Woo2, Young Joon Lee1

  • 1Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, South Korea; Lab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Immunology letters
|September 11, 2024
PubMed
概括

干白素-21 (IL-21) 通过增加纤维化相关基因和改变T细胞群来促进全身性硬化 (SSc). 阻断IL-21在小鼠模型中降低了SSc的严重程度,表明IL-21是治疗目标.